FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2095219757> ?p ?o ?g. }

• W2095219757 endingPage "493" @default.
• W2095219757 startingPage "480" @default.
• W2095219757 abstract "Benign prostatic hyperplasia (BPH) is characterized by an important inflammatory component. Stimulation of human prostate stromal cells from BPH tissues with proinflammatory cytokines leads to secretion of IL-8, a chemokine involved in BPH pathogenesis. The vitamin D receptor (VDR) agonist elocalcitol can arrest prostate growth in BPH patients, but its mechanism of action in this pathology is still incompletely understood.IL-8 levels were measured by real-time RT-PCR and ELISA. NF-kappaB translocation and COX-2 expression were evaluated by confocal microscopy. RhoA and Rho-kinase (ROCK) gene expression and functional activity were studied by real-time RT-PCR, immuno-kinase assays, Western blot analysis, confocal microscopy, and cell invasion.Stimulation of BPH cells with IL-8 activates the calcium-sensitizing RhoA/ROCK pathway, as demonstrated by the increased membrane translocation of RhoA and by phosphorylation of the ROCK substrate myosin phosphatase target subunit 1 (MYPT-1). In agreement with these data, C3 exoenzyme, a selective RhoA inhibitor, inhibits IL-8-induced invasion of BPH cells. The VDR agonist elocalcitol significantly inhibits IL-8 production by BPH cells stimulated with inflammatory cytokines, and IL-8-induced proliferation of BPH cells. In addition, elocalcitol inhibits IL-8-induced membrane translocation of RhoA and MYPT-1 phosphorylation in BPH cells, and inhibits dose-dependently their IL-8-dependent invasion. The inhibition induced by elocalcitol of IL-8 production by BPH cells is accompanied by decreased COX-2 expression and PGE(2) production and by arrest of NF-kappaB p65 nuclear translocation, associated with inhibition of the RhoA/ROCK pathway.These data provide a mechanistic explanation for the anti-proliferative and anti-inflammatory properties of elocalcitol in BPH cells." @default.
• W2095219757 created "2016-06-24" @default.
• W2095219757 creator A5000897968 @default.
• W2095219757 creator A5005595984 @default.
• W2095219757 creator A5007540595 @default.
• W2095219757 creator A5012539089 @default.
• W2095219757 creator A5020102317 @default.
• W2095219757 creator A5044220964 @default.
• W2095219757 creator A5049759930 @default.
• W2095219757 creator A5052670258 @default.
• W2095219757 creator A5056223367 @default.
• W2095219757 creator A5057446486 @default.
• W2095219757 creator A5058458204 @default.
• W2095219757 creator A5060379271 @default.
• W2095219757 creator A5085623794 @default.
• W2095219757 creator A5090687110 @default.
• W2095219757 date "2008-12-23" @default.
• W2095219757 modified "2023-10-13" @default.
• W2095219757 title "The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kB pathways" @default.
• W2095219757 cites W1602538488 @default.
• W2095219757 cites W1664645310 @default.
• W2095219757 cites W184020152 @default.
• W2095219757 cites W1872583110 @default.
• W2095219757 cites W1964621103 @default.
• W2095219757 cites W1965831940 @default.
• W2095219757 cites W1966140741 @default.
• W2095219757 cites W1966825446 @default.
• W2095219757 cites W1969035452 @default.
• W2095219757 cites W1974062591 @default.
• W2095219757 cites W1974557172 @default.
• W2095219757 cites W1976174932 @default.
• W2095219757 cites W1977130141 @default.
• W2095219757 cites W1977598211 @default.
• W2095219757 cites W1981147501 @default.
• W2095219757 cites W1984994493 @default.
• W2095219757 cites W1986878226 @default.
• W2095219757 cites W1988222534 @default.
• W2095219757 cites W1988743962 @default.
• W2095219757 cites W1990773600 @default.
• W2095219757 cites W1994624472 @default.
• W2095219757 cites W1994888948 @default.
• W2095219757 cites W1999066258 @default.
• W2095219757 cites W2003551606 @default.
• W2095219757 cites W2026644677 @default.
• W2095219757 cites W2034512273 @default.
• W2095219757 cites W2038075677 @default.
• W2095219757 cites W2038679265 @default.
• W2095219757 cites W2045525995 @default.
• W2095219757 cites W2051874402 @default.
• W2095219757 cites W2058048513 @default.
• W2095219757 cites W2068879625 @default.
• W2095219757 cites W2069544210 @default.
• W2095219757 cites W2071035219 @default.
• W2095219757 cites W2071873634 @default.
• W2095219757 cites W2077792958 @default.
• W2095219757 cites W2080590768 @default.
• W2095219757 cites W2086044289 @default.
• W2095219757 cites W2088483796 @default.
• W2095219757 cites W2098703441 @default.
• W2095219757 cites W2103230017 @default.
• W2095219757 cites W2111778006 @default.
• W2095219757 cites W2112334521 @default.
• W2095219757 cites W2126853519 @default.
• W2095219757 cites W2130842406 @default.
• W2095219757 cites W2131412807 @default.
• W2095219757 cites W2134178879 @default.
• W2095219757 cites W2136724125 @default.
• W2095219757 cites W2138742704 @default.
• W2095219757 cites W2143841173 @default.
• W2095219757 cites W2153911324 @default.
• W2095219757 cites W2157834851 @default.
• W2095219757 cites W2161882037 @default.
• W2095219757 cites W2163525357 @default.
• W2095219757 cites W2164360357 @default.
• W2095219757 cites W2168091755 @default.
• W2095219757 cites W2236421686 @default.
• W2095219757 cites W2313658969 @default.
• W2095219757 cites W25458998 @default.
• W2095219757 doi "https://doi.org/10.1002/pros.20896" @default.
• W2095219757 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19107880" @default.
• W2095219757 hasPublicationYear "2008" @default.
• W2095219757 type Work @default.
• W2095219757 sameAs 2095219757 @default.
• W2095219757 citedByCount "94" @default.
• W2095219757 countsByYear W20952197572012 @default.
• W2095219757 countsByYear W20952197572013 @default.
• W2095219757 countsByYear W20952197572014 @default.
• W2095219757 countsByYear W20952197572015 @default.
• W2095219757 countsByYear W20952197572016 @default.
• W2095219757 countsByYear W20952197572017 @default.
• W2095219757 countsByYear W20952197572018 @default.
• W2095219757 countsByYear W20952197572019 @default.
• W2095219757 countsByYear W20952197572020 @default.
• W2095219757 countsByYear W20952197572021 @default.
• W2095219757 countsByYear W20952197572022 @default.
• W2095219757 countsByYear W20952197572023 @default.
• W2095219757 crossrefType "journal-article" @default.
• W2095219757 hasAuthorship W2095219757A5000897968 @default.

• next